|
Patrick Rivers BSc, MBA
Partner / Head of Research
Aquilo Capital
USA
|
Patrick joined the investment team at Aquilo Capital in 2014. From 2005-2014 he worked as a research scientist in various drug development capacities for several public and private biotech firms, including Sutro Biopharma, Exelixis and Xoma. This experience includes research and development for preclinical and clinical stage products in oncology and inflammatory diseases. Patrick received his B.S. in Chemical Engineering at UCLA and his MBA from UC Berkeley's Haas School of Business.